Evidence supports initiation of the SGLT2 inhibitor dapagliflozin in patients with heart failure with preserved heart failure. The initial decline in estimated glomerular filtration rate (eGFR) after ...
Evidence continues to support initiation of sodium glucose cotransporter 2 inhibitors in patients with heart failure. The initial decline in estimated glomerular filtration rate (eGFR) after starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results